Literature DB >> 11015800

Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation.

A T McLellan1, D C Lewis, C P O'Brien, H D Kleber.   

Abstract

The effects of drug dependence on social systems has helped shape the generally held view that drug dependence is primarily a social problem, not a health problem. In turn, medical approaches to prevention and treatment are lacking. We examined evidence that drug (including alcohol) dependence is a chronic medical illness. A literature review compared the diagnoses, heritability, etiology (genetic and environmental factors), pathophysiology, and response to treatments (adherence and relapse) of drug dependence vs type 2 diabetes mellitus, hypertension, and asthma. Genetic heritability, personal choice, and environmental factors are comparably involved in the etiology and course of all of these disorders. Drug dependence produces significant and lasting changes in brain chemistry and function. Effective medications are available for treating nicotine, alcohol, and opiate dependence but not stimulant or marijuana dependence. Medication adherence and relapse rates are similar across these illnesses. Drug dependence generally has been treated as if it were an acute illness. Review results suggest that long-term care strategies of medication management and continued monitoring produce lasting benefits. Drug dependence should be insured, treated, and evaluated like other chronic illnesses. JAMA. 2000;284:1689-1695.

Entities:  

Mesh:

Year:  2000        PMID: 11015800     DOI: 10.1001/jama.284.13.1689

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  707 in total

1.  A call for papers. Substance abuse: innovations in primary care.

Authors:  P G O'Conner; J H Samet
Journal:  J Gen Intern Med       Date:  2001-01       Impact factor: 5.128

2.  Why health insurers should pay for addiction treatment. Treatment works and would lead to net societal benefits.

Authors:  D Breithaupt
Journal:  West J Med       Date:  2001-06

3.  Benefit-cost analysis of addiction treatment: methodological guidelines and empirical application using the DATCAP and ASI.

Authors:  Michael T French; Helena J Salomé; Jody L Sindelar; A Thomas McLellan
Journal:  Health Serv Res       Date:  2002-04       Impact factor: 3.402

4.  Policy progress for physician treatment of opiate addiction.

Authors:  Joseph O Merrill
Journal:  J Gen Intern Med       Date:  2002-05       Impact factor: 5.128

5.  Maintenance of reinforcement to address the chronic nature of drug addiction.

Authors:  Kenneth Silverman; Anthony DeFulio; Sigurdur O Sigurdsson
Journal:  Prev Med       Date:  2012-06-05       Impact factor: 4.018

6.  Heavy drinking and health promotion activities.

Authors:  Susan L Ettner; Michael T French; Ioana Popovici
Journal:  Soc Sci Med       Date:  2010-04-13       Impact factor: 4.634

Review 7.  Exercise-based treatments for substance use disorders: evidence, theory, and practicality.

Authors:  Sarah E Linke; Michael Ussher
Journal:  Am J Drug Alcohol Abuse       Date:  2014-11-14       Impact factor: 3.829

Review 8.  Heroin maintenance for chronic heroin-dependent individuals.

Authors:  Marica Ferri; Marina Davoli; Carlo A Perucci
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

9.  An experimental evaluation of recovery management checkups (RMC) for people with chronic substance use disorders.

Authors:  Michael Dennis; Christy K Scott; Rod Funk
Journal:  Eval Program Plann       Date:  2003-08

10.  Community-based relapse prevention for opiate dependents: a randomized community controlled trial.

Authors:  Masoomeh Maarefvand; Mostafa Eghlima; Hasan Rafiey; Mahdi Rahgozar; Nazanin Tadayyon; Abbas Deilamizadeh; Hamed Ekhtiari
Journal:  Community Ment Health J       Date:  2014-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.